HONG KONG,Jan. 9,2025-- Recently,Hong Kong-listed Yeahka (09923.HK) has launched an acquiring system in partnership with global payments technology leader Mastercard and its joint venture in China,Mas
01-10
Tango Extend provides organizations with a cost-effective,non-disruptive,reliable,and compliant mobile communications solution that enables access to essential business telephony features on mobile d
01-10
SAN JOSE,Calif.,Jan. 10,2025--In 2024,Complete Genomics,a pioneering genomic sequencing company,expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply
01-10
- Opening of the CES 2025 INCHEON-IFEZ Booth - Promoting IFEZ\'s Smart City Vision through Global Media
01-10
Enjoy a premium refund of up to 13% upon successful application HONG KONG,Jan. 9,2025--AIA Hong Kong & Macau announces the launch of the FlexiAchiever Savings Plan that integrates long-term wealth
01-10
LAS VEGAS,Jan. 9,2025-- On January 8th,at a concurrent event during the CES 2025 in Las Vegas,CHiQ was honored as one of the Global Smart Home Brands Top 10 by International Data Group (IDG). This acc
01-10
LAS VEGAS,Jan. 9,2025-- TECNO,a global innovative technology brand,celebrates a landmark achievement at CES 2025. The brand earned three awards: its selection as one of the 2024-2025 Global Top 10 Sm
01-10
TURFAN,China,Jan. 9,2025-- On January 9th,the 220 kV transmission project of theTurfan Fannan Boosting and Gathering Station was officially completed and commenced operation. This project is designed
01-10
Hyundai Motor Group is driving AI-powered innovation with the goal of applying intelligence across its core mobility solutions
01-10
HONG KONG,Jan. 10,2025-- Mirae Asset Global Investments (Hong Kong) Limited (referred to as "Mirae Asset") today announced the launch of Global X G2 Tech ETF (3402), designed to track the M
01-10
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
